The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Side-effect management › ASCO/NCCN guidlines now out › Reply To: ASCO/NCCN guidlines now out
February 17, 2018 at 5:21 pm #4696
Expert NurseRajni Kannan
I agree that a generalized way of treating patients based on grading alone is not the best method. Patients irAEs can be so individualized. Colitis may not always be diarrhea, it may abdominal pain and constipation. We have also had patients with grade 3 pancreatitis that are asymptomatic and only were diagnosed due to mandatory study labs that didn’t need the high dose steroids recommended by these guidelines.